Bill Few Associates Inc. Lowers Position in The Procter & Gamble Company (NYSE:PG)

Bill Few Associates Inc. trimmed its position in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 1.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 31,598 shares of the company’s stock after selling 360 shares during the quarter. Procter & Gamble accounts for approximately 2.0% of Bill Few Associates Inc.’s portfolio, making the stock its 11th largest holding. Bill Few Associates Inc.’s holdings in Procter & Gamble were worth $5,211,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the company. Alera Investment Advisors LLC increased its position in shares of Procter & Gamble by 1.2% during the first quarter. Alera Investment Advisors LLC now owns 5,007 shares of the company’s stock valued at $812,000 after buying an additional 60 shares during the period. Fiduciary Alliance LLC grew its holdings in shares of Procter & Gamble by 2.8% during the 2nd quarter. Fiduciary Alliance LLC now owns 2,261 shares of the company’s stock worth $371,000 after acquiring an additional 61 shares during the period. Demars Financial Group LLC lifted its stake in shares of Procter & Gamble by 4.4% in the 4th quarter. Demars Financial Group LLC now owns 1,497 shares of the company’s stock valued at $219,000 after purchasing an additional 63 shares during the period. LCM Capital Management Inc boosted its position in shares of Procter & Gamble by 1.1% during the first quarter. LCM Capital Management Inc now owns 5,701 shares of the company’s stock valued at $925,000 after purchasing an additional 63 shares in the last quarter. Finally, Prentice Wealth Management LLC grew its stake in Procter & Gamble by 1.6% in the second quarter. Prentice Wealth Management LLC now owns 4,059 shares of the company’s stock worth $669,000 after purchasing an additional 64 shares during the period. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

Procter & Gamble stock traded up $1.51 during midday trading on Wednesday, hitting $168.80. The stock had a trading volume of 4,953,791 shares, compared to its average volume of 6,651,881. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.51. The Procter & Gamble Company has a 52-week low of $141.45 and a 52-week high of $171.72. The company has a market capitalization of $398.39 billion, a PE ratio of 27.48, a P/E/G ratio of 3.64 and a beta of 0.41. The firm’s fifty day moving average is $166.93 and its two-hundred day moving average is $163.06.

Procter & Gamble (NYSE:PGGet Free Report) last issued its earnings results on Tuesday, July 30th. The company reported $1.40 earnings per share for the quarter, topping the consensus estimate of $1.37 by $0.03. The company had revenue of $20.53 billion during the quarter, compared to the consensus estimate of $20.69 billion. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. Procter & Gamble’s quarterly revenue was down .1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.37 EPS. On average, research analysts forecast that The Procter & Gamble Company will post 6.97 EPS for the current year.

Procter & Gamble Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be paid a dividend of $1.0065 per share. The ex-dividend date is Friday, July 19th. This represents a $4.03 annualized dividend and a yield of 2.39%. Procter & Gamble’s payout ratio is 65.85%.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on PG shares. Citigroup boosted their target price on shares of Procter & Gamble from $177.00 to $190.00 and gave the company a “buy” rating in a report on Wednesday, July 10th. JPMorgan Chase & Co. cut their price target on Procter & Gamble from $181.00 to $179.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 31st. TD Cowen started coverage on Procter & Gamble in a research note on Tuesday, July 23rd. They set a “buy” rating and a $189.00 price objective for the company. Dbs Bank downgraded shares of Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 1st. Finally, Stifel Nicolaus raised their price target on shares of Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a research report on Monday, July 22nd. Nine research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $173.95.

View Our Latest Research Report on Procter & Gamble

Insider Buying and Selling at Procter & Gamble

In other news, insider Balaji Purushothaman sold 8,842 shares of the company’s stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the sale, the insider now directly owns 11,537 shares of the company’s stock, valued at approximately $1,902,451.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, insider Balaji Purushothaman sold 8,842 shares of the business’s stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the sale, the insider now directly owns 11,537 shares in the company, valued at approximately $1,902,451.30. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Jon R. Moeller sold 72,174 shares of Procter & Gamble stock in a transaction dated Friday, August 9th. The stock was sold at an average price of $171.01, for a total value of $12,342,475.74. Following the completion of the transaction, the chief executive officer now owns 263,158 shares of the company’s stock, valued at approximately $45,002,649.58. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 125,462 shares of company stock worth $21,238,114. Insiders own 0.17% of the company’s stock.

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Stories

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.